- Home
- MRUS vs ETY Comparison
MRUS vs ETY Comparison
Compare MRUS & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- ETY
- Stock Information
- Founded
- MRUS 2003
- ETY 2006
- Country
- MRUS Netherlands
- ETY United States
- Employees
- MRUS N/A
- ETY N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- MRUS Health Care
- ETY Finance
- Exchange
- MRUS Nasdaq
- ETY Nasdaq
- Market Cap
- MRUS 2.7B
- ETY 2.1B
- IPO Year
- MRUS 2016
- ETY N/A
- Fundamental
- Price
- MRUS $42.77
- ETY $14.28
- Analyst Decision
- MRUS Strong Buy
- ETY
- Analyst Count
- MRUS 14
- ETY 0
- Target Price
- MRUS $87.00
- ETY N/A
- AVG Volume (30 Days)
- MRUS 786.0K
- ETY 247.3K
- Earning Date
- MRUS 05-07-2025
- ETY 01-01-0001
- Dividend Yield
- MRUS N/A
- ETY 7.21%
- EPS Growth
- MRUS N/A
- ETY N/A
- EPS
- MRUS N/A
- ETY N/A
- Revenue
- MRUS $54,732,000.00
- ETY N/A
- Revenue This Year
- MRUS $26.81
- ETY N/A
- Revenue Next Year
- MRUS $23.85
- ETY N/A
- P/E Ratio
- MRUS N/A
- ETY N/A
- Revenue Growth
- MRUS N/A
- ETY N/A
- 52 Week Low
- MRUS $33.19
- ETY $10.59
- 52 Week High
- MRUS $61.61
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- MRUS 49.60
- ETY 59.27
- Support Level
- MRUS $37.92
- ETY $13.99
- Resistance Level
- MRUS $46.36
- ETY $13.86
- Average True Range (ATR)
- MRUS 2.56
- ETY 0.27
- MACD
- MRUS -0.22
- ETY 0.13
- Stochastic Oscillator
- MRUS 57.46
- ETY 94.95
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.